Biological Assay Development, Validation & Maintenance

Critical Approaches for Critical Assays

Biological Assay Development, Validation & Maintenance
-バイオアッセイ開発、検証、メンテナンス学会-

2012年4月30日 - 5月2日 · The Fairmont Copley Plaza Hotel · Boston, MA

講演者

Svetlana Bergelson, Ph.D., Biogen Idec

Jamie Bird, M.Sc., Emergent BioSolutions

Leonard Blackwell, Ph.D., Pfizer

Bartek Bossak, Genentech, Inc

Kevin Brooks, Ph.D., Emergent BioSolutions

Sonia Connaughton, Ph.D., ImmunoGen

Gerald Feldman, Ph.D., CDER, US FDA

Jaya Goyal, Ph.D., Biogen Idec

Ulrike Herbrand, Ph.D., Charles River Biopharmaceutical Services GmbH, Germany

Xu-Rong Jiang, M.D., Ph.D., MedImmune

Jun Kim, MedImmune

Eloi Kpamegan, Ph.D., Novavax, Inc.

David Lansky, Ph.D., Precision Bioassay, Inc.

Janet Lathey, Ph.D., Emergent BioSolutions

Laureen E. Little, Ph.D., Quality Services

Katie Matys, M.S., PPD Vaccines and Biologics Lab

Mike Merges, M.Sc., Catalent Pharma Solutions

Catherine Ramsey, Ph.D., Biogen Idec

Renuka Pillutla, Ph.D., Bristol-Myers Squibb

Mike Sadick, Ph.D., Aptuit

Sally Seaver, Ph.D., Seaver Associates LLC

Timothy Schofield, M.A., Arlenda USA

Hongran Stone, Ph.D., Revance Therapeutics, Inc.

Tatyana Timiryasova, Ph.D., Sanofi Pasteur Inc.

Thomas Waerner, Ph.D., Boehringer Ingelheim RCV GmbH & Co KG, Germany

Rong-Rong Zhu, EMD Millipore